Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-9801 in Diabetic Neuropathy
NCT01813799Phase 2Completed
- Sponsor
- Dong-A ST
- Start
- Nov 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of DA-9801 in diabetic neuropathy, sponsored by Dong-A ST. Started Nov 2011; status: completed.
02
Drugs
DA-9801
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT01813799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01813799.